NDC properties for NDC 9 0597-0560
NDC item 00597056012
NDC 9 | 0597-0560 |
---|---|
NDC 10 | 0597-0560-12 |
NDC Item | 00597056012 |
packaging | 0.4 mL in 1 SYRINGE |
packaging | 1 in 1 TRAY |
FDA SPL set id | 784593 |
Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG LABEL |
NDC item 00597056520
NDC 9 | 0597-0565 |
---|---|
NDC 10 | 0597-0565-20 |
NDC Item | 00597056520 |
packaging | 2 KIT in 1 CARTON (0597-0565-20) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0560-12) / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET |
BLA | BLA761058 |
FDA SPL set id | 784593 |
Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2024-04-30 |
Marketing status | ACTIVE |
NDC item 82009014622
NDC 9 | 82009-146 |
---|---|
NDC 10 | 82009-146-22 |
NDC Item | 82009014622 |
packaging | 2 KIT in 1 CARTON (82009-146-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-147-11) / .4 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
BLA | BLA761058 |
FDA SPL set id | 784783 |
Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2024-04-30 |
Marketing status | ACTIVE |
NDC item 82009014711
NDC 9 | 82009-147 |
---|---|
NDC 10 | 82009-147-11 |
NDC Item | 82009014711 |
packaging | 0.4 mL in 1 SYRINGE |
packaging | 1 in 1 TRAY |
FDA SPL set id | 784783 |
Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
Label type | HUMAN PRESCRIPTION DRUG LABEL |